Invesco Nasdaq Future Gen 200 ETF Rating $21.17 +0.22 (+1.07%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$21.17 0.00 (-0.02%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Nasdaq Future Gen 200 ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.QQQS Aggregate RatingModerate Buy 2.71Holdings in QQQS have an aggregate rating of Moderate Buy based on 264 analyst ratings issued in the past year covering 45 companies (28.4% of the portfolio).QQQS Aggregate Price Target$21.17High Prediction$21.17Average Prediction$21.17Low Prediction$21.17Holdings in QQQS have an aggregate price target of $21.17 and a range of $21.17 to $21.17 covering 45 companies (28.4% of the portfolio).QQQS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold14 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Future Gen 200 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 QQQS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.17%PDEXPro-Dex$60.83-0.8%1.5662 of 5 stars3.00$52.00 -14.5%1Short Interest ↑News CoveragePositive News0.71%TTECTTEC$3.58-4.3%2.9536 of 5 stars2.50$10.83 202.6%4News Coverage0.69%LABStandard BioTools$1.16+2.7%2.1801 of 5 stars2.50$2.50 115.5%20.68%MVSTMicrovast$1.83+10.9%2.1083 of 5 stars3.00$3.00 63.9%10.68%OCGNOcugen$0.68+4.0%1.2357 of 5 stars3.00$6.33 832.2%3Positive News0.67%DBXDropbox$27.11+1.0%3.246 of 5 stars2.33$27.67 2.1%3Short Interest ↓Positive News0.67%CYRXCryoport$5.55-1.1%2.5286 of 5 stars2.83$11.67 110.2%6Analyst ForecastAnalyst RevisionNews Coverage0.66%ANABAnaptysBio$20.55+7.8%2.6612 of 5 stars2.70$33.63 63.6%10News CoveragePositive News0.66%GHGuardant Health$44.97-0.5%3.7945 of 5 stars3.05$49.00 9.0%21News Coverage0.66%GTGoodyear Tire & Rubber$9.75+1.0%3.7406 of 5 stars2.83$13.78 41.3%6Positive News0.66%PCRXPacira BioSciences$24.65+0.7%2.1212 of 5 stars2.33$26.67 8.2%90.65%KALVKalVista Pharmaceuticals$12.00+2.2%4.2417 of 5 stars3.13$24.83 106.9%8Positive News0.64%ERIIEnergy Recovery$14.83-0.3%4.5322 of 5 stars3.17$20.75 39.9%6News CoveragePositive News0.64%ANGOAngioDynamics$9.52+0.6%4.0658 of 5 stars3.00$14.00 47.1%2Positive News0.64%ALGMAllegro MicroSystems$18.06-4.6%2.7711 of 5 stars2.89$30.67 69.8%90.64%SUPNSupernus Pharmaceuticals$30.76+0.2%2.9581 of 5 stars2.33$36.00 17.0%3Analyst UpgradeNews Coverage0.63%SAGESage Therapeutics$7.43+0.8%4.0486 of 5 stars2.00$8.81 18.6%19Upcoming EarningsAnalyst RevisionNews CoverageGap Up0.63%INVAInnoviva$18.27+1.0%4.253 of 5 stars3.00$55.00 201.0%2Positive News0.63%ICUIICU Medical$138.67-0.3%3.9212 of 5 stars3.00$168.67 21.6%4Analyst Upgrade0.63%AVAVAeroVironment$147.61+2.6%3.4117 of 5 stars3.25$202.00 36.8%8Gap Up0.62%ADPTAdaptive Biotechnologies$7.33-2.1%3.8322 of 5 stars3.00$9.40 28.2%5Positive News0.62%GOGOGogo$6.97+1.0%3.8613 of 5 stars2.33$11.33 62.6%3News CoveragePositive News0.62%VSATViasat$8.49+3.9%4.3586 of 5 stars2.38$14.57 71.6%8Analyst ForecastAnalyst Revision0.61%RDWRRadware$21.28+1.0%3.3986 of 5 stars2.33$27.00 26.9%3Short Interest ↑News CoveragePositive NewsHigh Trading Volume0.61%FATEFate Therapeutics$1.11+5.7%3.3883 of 5 stars2.22$5.43 389.1%9News CoverageGap Down0.61%IDCCInterDigital$189.27-3.9%1.9309 of 5 stars2.50$130.00 -31.3%2Positive News0.60%PACBPacific Biosciences of California$1.17-2.5%2.4743 of 5 stars2.45$2.45 109.4%110.60%ITRIItron$103.26+1.6%4.1281 of 5 stars2.73$127.64 23.6%11Analyst ForecastPositive News0.60%TILEInterface$18.58-0.4%4.5385 of 5 stars3.00$30.00 61.5%1Analyst ForecastNews CoveragePositive NewsGap Up0.60%TCMDTactile Systems Technology$13.33-0.1%3.2341 of 5 stars2.00$18.00 35.0%3Positive News0.59%GTXGarrett Motion$9.00+0.6%3.4138 of 5 stars3.00$12.00 33.4%1Insider TradeNews Coverage0.59%IPGPIPG Photonics$53.30+2.8%4.3553 of 5 stars2.43$85.40 60.2%7Analyst RevisionNews CoveragePositive News0.59%OSISOSI Systems$194.19+2.6%3.6616 of 5 stars2.83$213.33 9.9%6Upcoming Earnings0.59%NEONNeonode$9.06+6.6%1.4724 of 5 stars3.00$16.50 82.1%10.59%ABUSArbutus Biopharma$3.15+2.9%1.9691 of 5 stars3.00$5.50 74.6%4Positive News0.58%CVLTCommvault Systems$149.74-0.9%4.2522 of 5 stars2.50$158.00 5.5%10Analyst ForecastNews CoveragePositive News0.58%MMSIMerit Medical Systems$90.89+0.4%4.7716 of 5 stars3.00$114.33 25.8%10Upcoming EarningsShort Interest ↓News CoveragePositive News0.58%TBPHTheravance Biopharma$8.62+0.2%1.8862 of 5 stars2.25$11.33 31.5%4Positive News0.57%VIAVViavi Solutions$9.86-0.4%4.5728 of 5 stars2.44$12.50 26.8%9Gap Up0.57%MCFTMasterCraft Boat$16.00+3.7%3.6123 of 5 stars2.17$19.60 22.5%6Analyst UpgradeInsider TradeNews Coverage0.57%IMMRImmersion$7.07-3.0%3.4743 of 5 stars3.00$12.25 73.3%2Positive News0.57%IGMSIGM Biosciences$1.22+2.5%3.1071 of 5 stars1.90$5.50 350.8%10News Coverage0.57%AQSTAquestive Therapeutics$2.51+0.4%1.8177 of 5 stars3.14$10.67 325.0%7Gap Down0.57%AKBAAkebia Therapeutics$2.06+8.4%3.37 of 5 stars3.00$6.50 215.5%3Gap Up0.57%AEHRAehr Test Systems$8.09-0.9%3.6362 of 5 stars3.00$25.00 209.0%1Gap Up This page (NASDAQ:QQQS) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Future Gen 200 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Future Gen 200 ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.